Cambridge, MA, United States of America

Yong Chang

This inventor holds 1 USPTO granted patent. Top assignee: Intellia Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong Chang. Retrieved from https://idiyas.com/inventor/yong-chang-9k5d1gjg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yong Chang - Innovator in Genetic Engineering

Introduction

Yong Chang is a prominent inventor based in Cambridge, MA, known for his contributions to the field of genetic engineering. He has made significant strides in developing innovative solutions that harness the power of RNA-guided technologies.

Latest Patents

Yong Chang holds a patent titled "Compositions and Methods Comprising a TTR Guide RNA and a Polynucleotide Encoding an RNA-Guided DNA Binding Agent." This patent reflects his expertise in creating compositions that can potentially revolutionize therapeutic approaches in genetic medicine. He has 1 patent to his name, showcasing his commitment to advancing scientific knowledge.

Career Highlights

Chang is currently employed at Intellia Therapeutics, Inc., a leading biotechnology company focused on developing transformative therapies using CRISPR technology. His work at Intellia Therapeutics has positioned him at the forefront of innovation in the biotech industry.

Collaborations

Yong Chang collaborates with several talented individuals in his field, including his coworker Seth C. Alexander. Their combined expertise contributes to the advancement of groundbreaking research and development in genetic engineering.

Conclusion

Yong Chang is a dedicated inventor whose work in genetic engineering continues to push the boundaries of science. His contributions, particularly in RNA-guided technologies, hold promise for future therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…